| Patient | Geronimo |
|---|---|
| Date of birth | 1829-06-01 |
| Identifiers | MRN HR-NI016-SYN-TD; SSN (made up) 000-16-4729 |
| Document date | 1906-10-28 |
| Author | Roberta Whitehorse-Lindgren, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Sixteen-week review after twelve sessions of therapy. [S]
Geronimo returns sixteen weeks after intake, with the interpreter. He finished the twelfth session of cognitive processing therapy last week. Nightmares now come about once every two weeks, and he sleeps six hours most nights. He had one evening of heavy drinking three weeks ago, which he raised himself; since then he has had a single drink on a few evenings. He takes sertraline 50 mg, naltrexone and thiamine without side effects and has not fallen. His stool test was negative and the hepatitis C and B tests show no infection and no immunity to hepatitis B. He says he prays in his own way and that this is part of how he is doing; he did not describe it and was not asked. He wants his zoster and Tdap vaccines today. [S]
| Element | Detail |
|---|---|
| Therapy | Twelve of twelve sessions completed |
| PCL-5 | 24, from 56 |
| PHQ-9 | 4 |
| AUDIT | 5, from 19 |
| PEth | 14 ng/mL |
| Screening results | Stool test and hepatitis C negative; not infected with or immune to hepatitis B |
| System | Result | Finding |
|---|---|---|
| Psychiatric | Positive | Nightmares about once every two weeks; mood steady; no thoughts of suicide |
| Gastrointestinal | Negative | No nausea or abdominal pain |
| Neurological | Negative | No dizziness or falls |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Thiamine 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1906-07-08 | active | S |
| Naltrexone 50 mg oral tablet, one tablet daily; carries a wallet card saying that naltrexone blocks opioid pain medicines | One tablet daily | Oral route | 1906-07-22 | active | S |
| Sertraline 25 mg oral tablet, one tablet each morning, raised to 50 mg after the sodium check | One tablet each morning | Oral route | 1906-08-19 to 1906-09-23 | completed | S |
| Sertraline 50 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1906-09-23 | active | S |
| Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for fever or aches, no more than 2,000 mg a day while his liver recovers | One or two tablets every 6 hours as needed, no more than 2,000 mg a day | Oral route | 1906-09-02 to 1906-09-16 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1906-10-28 | Body height | 173 | cm | S |
| 1906-10-28 | Body weight | 67.6 | kg | S |
| 1906-10-28 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 1906-10-28 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1906-10-28 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1906-10-28 | Heart rate | 70 | /min | S |
| 1906-10-28 | Respiratory rate | 16 | /min | S |
| 1906-10-28 | Body temperature | 36.5 | Cel | S |
| 1906-10-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1906-10-28 | PTSD PCL-5 score [PCL-5] | 24 | {score} | S | ||
| 1906-10-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1906-10-28 | Total score [AUDIT] | 5 | {score} | S | ||
| 1906-10-28 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 29 | U/L | 10-40 U/L | Normal | S |
| 1906-10-28 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 25 | U/L | 7-56 U/L | Normal | S |
| 1906-10-28 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 48 | U/L | 8-61 U/L | Normal | S |
| 1906-10-28 | Phosphatidylethanol [Mass/volume] in Blood | 14 | ng/mL | <=20 ng/mL | Normal | S |
Vital signs recorded on 1906-10-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 128/76 seated and 126/74 standing; pulse 70; weight 67.6 kg, BMI 22.6 |
| Mental status | Relaxed and humorous; full range of affect; no thoughts of suicide or of harming anyone |
| Gait | Steady; Timed Up and Go 11 seconds |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Poor sleep for many years with nightmares and unwanted memories of past violence, worse over the past year; drinks at night to sleep; cause to be assessed | resolved | confirmed | G47.00 | S — Synthetic presenting problem anchored to the documented killing of his family and his years of war; resolved into the diagnosis of post-traumatic stress disorder at the consultation. Not a claim about his real sleep. |
| Post-traumatic stress disorder, chronic, confirmed with the CAPS-5 interview (PCL-5 56 at intake); prolonged grief disorder considered and criteria not met | active | confirmed | F43.12 | S — Synthetic modern diagnosis made at the consultation by current criteria; not a retrospective diagnosis of the historical person. |
| Alcohol use disorder, moderate (four DSM-5-TR criteria): drinking at night to sleep, more than intended, unable to cut down, and a fall walking home after drinking; AUDIT 19; liver tests show the pattern of heavy drinking | active | confirmed | F10.20 | S — Synthetic modern diagnosis anchored to his own statement that he was twice jailed for drinking whisky as a prisoner of war; not a claim about his real drinking. |
| A fall in the past month while walking home at night after drinking: bruised left hip, no fracture on examination; Timed Up and Go 13 seconds | active | confirmed | Z91.81 | S — Synthetic fall-risk finding; it is not his documented last fall, which is history after the episode. |
| Acute bronchitis with cough and low fever for six days, chest X-ray clear, oxygen saturation 95%; treated without antibiotics; resolved | resolved | confirmed | J20.9 | S — Synthetic self-limited illness; not a historical claim and not his documented last illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PTSD symptom severity (PCL-5) | Baseline, then every visit during treatment | Completed today | 24, from 56 |
| Self-management | Trauma-focused psychotherapy (cognitive processing therapy), sessions attended | Weekly for twelve sessions | Completed today | Twelve of twelve sessions completed; monthly boosters planned |
| Survey | Depressive symptoms (PHQ-9) | Baseline, then monthly during active treatment | Completed today | 4, from 11; item 9 scored 0 |
| Survey | Suicide-risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; 988 card carried |
| Self-management | Drinking since the last visit, against his own goal | Every visit | Completed today | One heavy evening three weeks ago; otherwise a single drink on a few evenings; AUDIT 5 |
| Laboratory | Liver tests (AST, ALT, GGT) on naltrexone | Before starting, at four to six weeks, then every three to six months | Completed today | AST 29, ALT 25, GGT 48 U/L: normal |
| Laboratory | PEth, a blood marker of drinking over the past two to four weeks | At baseline and every one to three months during treatment, with consent | Completed today | 14 ng/mL, from 41 |
| Medication safety | Naltrexone safety: opioid use, nausea, wallet card | Every visit | Completed today | No opioid use; no side effects |
| Medication safety | SSRI safety: sodium, bleeding, falls and side effects | Sodium within the first month in older adults; review at each dose change | Up to date | Sodium 137 mmol/L five weeks ago; no bleeding, dizziness or falls on 50 mg |
| Medication safety | Prazosin for nightmares | When nightmares persist despite first-line treatment | Not indicated | Nightmares about once every two weeks; not needed |
| Examination | Falls and gait (Timed Up and Go), orthostatic blood pressure | At intake and every visit after a fall | Completed today | Timed Up and Go 11 seconds; no orthostatic drop; no falls |
| Self-management | Traditional healing alongside clinic care, at his choice | Every visit | Completed today | His own prayer and ways continue, as he chooses; nothing asked |
Goal progress:
Immunizations given today: Tdap vaccine; no booster he can recall; Recombinant zoster vaccine, first of two doses [S]
Guideline basis: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults (2017); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The Healthcare Professional's Core Resource on Alcohol (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Special General Memorandum 94-08: Statement of Policy for the Traditional Cultural Advocacy Program (1994); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); Adult Immunization Schedule by Age (2026)
Follow-up: Tdap and the first recombinant zoster dose given today; second zoster dose in two to six months. Hepatitis B vaccination offered and to be decided at the next visit. Review in three months with the PCL-5. Booster therapy sessions monthly. Call the clinic or 988 at any hour. [S]